Bioorganic & Medicinal Chemistry Letters
2003-10-20
Design and synthesis of novel CCR3 antagonists.
Leyi Gong, J Heather Hogg, James Collier, Robert S Wilhelm, Carol Soderberg
文献索引:Bioorg. Med. Chem. Lett. 13(20) , 3597-600, (2003)
全文:HTML全文
摘要
As part of our investigation into the development of potent CCR3 antagonists, a series of piperidine analogues was designed and prepared. Exploration of the piperidine core examined both the basicity and the location of a nitrogen, as well as conformational variants. The bicyclo-piperidine 24c was found to be the most potent inhibitor of CCR3 with an IC(50) of 0.0082 microM in the binding assay and 0.0024 microM in the chemotaxis assay.
相关化合物
相关文献:
2011-09-02
[J. Org. Chem. 76(17) , 7040-7, (2011)]